Emmanuel Tsochatzis

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

Vasiliki Arvaniti, Gennaro D’Amico, Giuseppe Di Fede et al. · Gastroenterology · 2010 · 1.1K citations

Hepatology, Healthcare-associated Infection, Pathology +6

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome, M. Sasso, Jonathan J Deeks et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 729 citations · Full text

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Ankur Srivastava, Ruth Gailer, Sudeep Tanwar et al. · Journal of Hepatology · 2019 · 415 citations · Full text

Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis

Marco Senzolo, Teresa Maria Sartori, Valeria Rossetto et al. · Liver International · 2012 · 329 citations